🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: L-phenylalanine mustard

Found 732 matching trials

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

PHASE2

The purpose of this study is to find out if removing a specific type of whi...

Status

Terminated

Location

Memorial SloanKettering Cancer Center

Start Date

2018-07-23

Trial ID

NCT03615144

Treatments Being Tested

Melphalan Thiotepa Clofarabine Fludarabine Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®)CliniMACS reagents

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

PHASE2

RATIONALE: Drugs used in chemotherapy, such as melphalan, leucovorin, oxali...

Status

Completed

Location

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support

Start Date

2004-12

Trial ID

NCT00103298

Treatments Being Tested

FOLFOX regimen fluorouracil isolated perfusion leucovorin calcium melphalan oxaliplatin

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

PHASE2

RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...

Status

Completed

Location

Knight Cancer Institute at Oregon Health and Science University

Start Date

2005-03

Trial ID

NCT00238433

Treatments Being Tested

filgrastim busulfan melphalan thiotepa bone marrow ablation with stem cell support peripheral blood stem cell transplantation

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

PHASE1

The purpose of this study is to evaluate the safety and efficacy of Bendamu...

Status

Completed

Location

Weill Cornell Medical College

Start Date

2009-04-23

Trial ID

NCT00916058

Treatments Being Tested

Bendamustine Melphalan Bendamustine Bendamustine Bendamustine Bendamustine Bendamustine

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

PHASE1

This pilot clinical trial studies the side effects and best dose of ruxolit...

Status

Completed

Location

City of Hope Medical Center

Start Date

2016-11-13

Trial ID

NCT02917096

Treatments Being Tested

Allogeneic Hematopoietic Stem Cell Transplantation Fludarabine Fludarabine Phosphate Laboratory Biomarker Analysis Melphalan Pharmacological Study Ruxolitinib Ruxolitinib Phosphate Sirolimus Tacrolimus

Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis

PHASE2

This non-randomised open-label prospective pilot study evaluates the safety...

Status

Unknown

Location

Kirill Zykov

Start Date

2018-06-20

Trial ID

NCT04278040

Treatments Being Tested

Melphalan

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

PHASE1

RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...

Status

Terminated

Location

Mayo Clinic Scottsdale

Start Date

2004-01-22

Trial ID

NCT00052884

Treatments Being Tested

filgrastim amifostine trihydrate melphalan bone marrow ablation with stem cell support peripheral blood stem cell transplantation

Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia

PHASE2

This single-center, prospective, open-label, comparator study, blind for ce...

Status

Unknown

Location

Kirill Zykov

Start Date

2020-04-30

Trial ID

NCT04380376

Treatments Being Tested

Melphalan Standard of care

Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

PHASE1

RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...

Status

Completed

Location

Multiple Locations

Start Date

2001-01

Trial ID

NCT00550784

Treatments Being Tested

filgrastim cisplatin cyclophosphamide melphalan paclitaxel topotecan hydrochloride TdT-mediated dUTP nick end labeling assay gene expression analysis immunohistochemistry staining method pharmacological study peripheral blood stem cell transplantation

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

PHASE1

This phase I/II trial studies the side effects and best dose of melphalan w...

Status

Completed

Location

University of Minnesota/Masonic Cancer Center

Start Date

2005-09-15

Trial ID

NCT00303849

Treatments Being Tested

Carboplatin Etoposide Etoposide Phosphate Laboratory Biomarker Analysis Mannitol Melphalan Quality-of-Life Assessment Sodium Thiosulfate

Previous Next